References:[1]. Cho, N.H., et al., IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research & Clinical Practice, 2018. 138: p. 271.[2]. 廖涌, 中国糖尿病的流行病学现状及展望. 重庆医科大学学报, 2015(7): 第1042-1045页.[3]. Klokkevold, P.R., Cone Beam Computed Tomography for the Dental Implant Patient. J Calif Dent Assoc, 2015. 43(9): p. 521-30.[4]. Moraschini, V., et al., Evaluation of survival and success rates of dental implants reported in longitudinal studies with a follow-up period of at least 10 years: a systematic review. Int J Oral Maxillofac Surg, 2015. 44(3): p. 377-88.[5]. Giglio, M.J., et al., Histomorphometric study of bone healing around laminar implants in experimental diabetes. Implant Dentistry, 2000. 9(2): p. 143-149.[6]. Oates, T.W., et al., A critical review of diabetes, glycemic control, and dental implant therapy. Clin Oral Implants Res, 2013. 24(2): p. 117-27.[7]. Aguilar-Salvatierra, A., et al., Peri-implant evaluation of immediately loaded implants placed in esthetic zone in patients with diabetes mellitus type 2: a two-year study. Clin Oral Implants Res, 2016. 27(2): p. 156-61.[8]. Jadhav, R., et al., Dental implant in diabetic patients: Statement of facts. 2015. 6(2): p. 47.[9]. Naujokat, H., B. Kunzendorf and J. Wiltfang, Dental implants and diabetes mellitus-a systematic review. Int J Implant Dent, 2016. 2(1): p. 5.[10]. Kohnert, K.D., et al., Chronic hyperglycemia but not glucose variability determines HbA1c levels in well-controlled patients with type 2 diabetes. Diabetes Res Clin Pract, 2007. 77(3): p. 420-426.[11]. 周健等, 应用动态血糖监测系统评估2型糖尿病患者日内及日间血糖波动幅度. 中华内分泌代谢杂志, 2006. 22(3): 第286-288页.[12]. 刘乃彬, 血糖波动对2型糖尿病大鼠种植体骨结合影响的实验研究, 2013, 第四军医大学.[13]. Hegab, A.F., Dental Infection and Diabetes: The Cycle. 2015. 3.[14]. Keenan, J.R. and A. Veitz-Keenan, Antibiotic prophylaxis for dental implant placement? Evid Based Dent, 2015. 16(2): p. 52-3.[15]. Escalante, M.G., et al., Comparison of Azithromycin and Amoxicillin Before Dental Implant Placement: An Exploratory Study of Bioavailability and Resolution of Postoperative Inflammation. J Periodontol, 2015. 86(11): p. 1190-200.[16]. Arduino, P.G., et al., Single preoperative dose of prophylactic amoxicillin versus a 2-day postoperative course in dental implant surgery: A two-centre randomised controlled trial. Eur J Oral Implantol, 2015. 8(2): p. 143-9.[17]. Genovesi, A., et al., The efficacy of 0.12% chlorhexidine versus 0.12% chlorhexidine plus hyaluronic acid mouthwash on healing of submerged single implant insertion areas: a short-term randomized controlled clinical trial. Int J Dent Hyg, 2017. 15(1): p. 65-72.[18]. 徐晓明等, 口腔专业护理对糖尿病患者种植体周围炎干预评价. 现代中西医结合杂志, 2015(9): 第1011-1013页.[19]. Anner, R., et al., Smoking, diabetes mellitus, periodontitis, and supportive periodontal treatment as factors associated with dental implant survival: a long-term retrospective evaluation of patients followed for up to 10 years. 2010. 19(1): p. 57-64.[20]. Ghiraldini, B., et al., Influence of Glycemic Control on Peri-Implant Bone Healing: 12-Month Outcomes of Local Release of Bone-Related Factors and Implant Stabilization in Type 2 Diabetics. Clin Implant Dent Relat Res, 2016. 18(4): p. 801-9.[21]. Thomas, D.M., et al., Insulin receptor expression in primary and cultured osteoclast-like cells. Bone, 1998. 23(3): p. 181-6.[22]. Vestergaard, P., Bone metabolism in type 2 diabetes and role of thiazolidinediones. Curr Opin Endocrinol Diabetes Obes, 2009. 16(2): p. 125-31.[23]. Conover, C.A., et al., Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoid. Endocrinology, 1996. 137(8): p. 3295-301.[24]. McCracken, M.S., et al., Bone associated with implants in diabetic and insulin-treated rats. Clin Oral Implants Res, 2006. 17(5): p. 495-500.[25]. Zou, G.K., et al., Effects of local delivery of bFGF from PLGA microspheres on osseointegration around implants in diabetic rats. Oral Surgery Oral Medicine Oral Pathology & Oral Radiology, 2012. 114(3): p. 284-289.[26]. Wang, F., et al., Sustained release of insulin-like growth factor-1 from poly(lactide-co-glycolide) microspheres improves osseointegration of dental implants in type 2 diabetic rats. Eur J Pharmacol, 2010. 640(1-3): p. 226-32.[27]. Kanazawa, I., T. Yamaguchi and T. Sugimoto, Baseline serum total adiponectin level is positively associated with changes in bone mineral density after 1-year treatment of type 2 diabetes mellitus. Metabolism-clinical & Experimental, 2010. 59(9): p. 1252-1256.[28]. Luo, E., et al., Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbits. Acta Biomater, 2012. 8(2): p. 734-43.[29]. Claustrat, B., J. Brun and G. Chazot, The basic physiology and pathophysiology of melatonin. Sleep Medicine Reviews, 2005. 9(1): p. 11-24.[30]. Yildirimturk, S., et al., The effects of supplemental melatonin administration on the healing of bone defects in streptozotocin-induced diabetic rats. J Appl Oral Sci, 2016. 24(3): p. 239-49.[31]. Guo, T., et al., Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy. Diabetes, 2012. 61(10): p. 2414-23.[32]. Wallner, C., et al., Inhibition of GDF8 (Myostatin) accelerates bone regeneration in diabetes mellitus type 2. Scientific Reports, 2017. 7(1).[33]. Yeo, I.S., Reality of Dental Implant Surface Modification: A Short Literature Review. Open Biomedical Engineering Journal, 2014. 8(8): p. 114-119.[34]. Li, X., et al., Osseointegration of chitosan coated porous titanium alloy implant by reactive oxygen species-mediated activation of the PI3K/AKT pathway under diabetic conditions. Biomaterials, 2015. 36: p. 44-54.[35]. Arai, Y., T. Miyayama and S. Hirano, Difference in the toxicity mechanism between ion and nanoparticle forms of silver in the mouse lung and in macrophages. Toxicology, 2015. 328(xxx): p. 84-92.[36]. Qin, H., et al., Silver nanoparticles promote osteogenic differentiation of human urine-derived stem cells at noncytotoxic concentrations. Int J Nanomedicine, 2014. 2014(Issue 1): p. 2469-2478.[37]. Qin, H., et al., Antimicrobial and Osteogenic Properties of Silver Ion Implanted Stainless Steel. Acs Appl Mater Interfaces, 2015. 7(20): p. 10785-10794.[38]. Zhong, X., et al., Titanium Surface Priming with Phase-Transited Lysozyme to Establish a Silver Nanoparticle-Loaded Chitosan/Hyaluronic Acid Antibacterial Multilayer via Layer-by-Layer Self-Assembly. Plos One, 2016. 11(1): p. e0146957.[39]. Richardson, J.J., M. Bj?rnmalm and F. Caruso, Multilayer assembly. Technology-driven layer-by-layer assembly of nanofilms. Science, 2015. 348(6233): p. aaa2491.[40]. 吴霞等, 大鼠下颌骨来源的成骨细胞对甲硝唑和替硝唑的转运. 口腔颌面修复学杂志, 2007. 8(1): 第59-62页.[41]. Sykaras, N., et al., Osseointegration of dental implants complexed with rhBMP-2: a comparative histomorphometric and radiographic evaluation. Int J Oral Maxillofac Implants, 2004. 19(5): p. 667-678.[42]. 刘洪臣, 人工种植体全身给药装置, 2007, CN.[43]. 张爽, 周毅与王贻宁. 牙种植体载药基台的设计制作及体外抑菌效果初探. in 第八次全国口腔修复学学术年会论文汇编. 2014.[44]. SMaxwell, C. and R. JWood, Update on vitamin D and type 2 diabetes. Nutrition Reviews, 2011. 69(5): p. 291-295.[45]. Xiong, Y., et al., 1α,25-Dihydroxyvitamin D3 increases implant osseointegration in diabetic mice partly through FoxO1 inactivation in osteoblasts. Biochem Biophys Res Commun, 2017. 6(3): p. 320-324.[46]. Dong, L. and C. Wang, Harnessing the power of macrophages/monocytes for enhanced bone tissue engineering. Trends in Biotechnology, 2013. 31(6): p. 342-346.[47]. Z, H., et al., Immunomodulatory ECM-like Microspheres for Accelerated Bone Regeneration in Diabetes Mellitus. Acs Appl Mater Interfaces, 2018. 10(3). |